174 related articles for article (PubMed ID: 37175972)
1. Natural Compounds, Optimal Combination of Brusatol and Polydatin Promote Anti-Tumor Effect in Breast Cancer by Targeting Nrf2 Signaling Pathway.
Li J; Zhang J; Zhu Y; Afolabi LO; Chen L; Feng X
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175972
[TBL] [Abstract][Full Text] [Related]
2. Anticancer Effects of Thymoquinone through the Antioxidant Activity, Upregulation of Nrf2, and Downregulation of PD-L1 in Triple-Negative Breast Cancer Cells.
Adinew GM; Messeha SS; Taka E; Badisa RB; Soliman KFA
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432484
[TBL] [Abstract][Full Text] [Related]
3. Bilirubin mediated oxidative stress involves antioxidant response activation via Nrf2 pathway.
Qaisiya M; Coda Zabetta CD; Bellarosa C; Tiribelli C
Cell Signal; 2014 Mar; 26(3):512-20. PubMed ID: 24308969
[TBL] [Abstract][Full Text] [Related]
4. An in vitro study on the reversal of epithelial to mesenchymal transition by brusatol and its synergistic properties in triple-negative breast cancer cells.
Chandrasekaran J; Balasubramaniam J; Sellamuthu A; Ravi A
J Pharm Pharmacol; 2021 Apr; 73(6):749-757. PubMed ID: 33769483
[TBL] [Abstract][Full Text] [Related]
5. A loop involving NRF2, miR-29b-1-5p and AKT, regulates cell fate of MDA-MB-231 triple-negative breast cancer cells.
De Blasio A; Di Fiore R; Pratelli G; Drago-Ferrante R; Saliba C; Baldacchino S; Grech G; Scerri C; Vento R; Tesoriere G
J Cell Physiol; 2020 Feb; 235(2):629-637. PubMed ID: 31313842
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic activities of brusatol in human non-small cell lung cancer cells: Involvement of ROS-mediated mitochondrial-dependent pathway and inhibition of Nrf2-mediated antioxidant response.
Xie J; Lai Z; Zheng X; Liao H; Xian Y; Li Q; Wu J; Ip S; Xie Y; Chen J; Su Z; Lin Z; Yang X
Toxicology; 2021 Mar; 451():152680. PubMed ID: 33465425
[TBL] [Abstract][Full Text] [Related]
7. Nrf2/ARE pathway activation, HO-1 and NQO1 induction by polychlorinated biphenyl quinone is associated with reactive oxygen species and PI3K/AKT signaling.
Li L; Dong H; Song E; Xu X; Liu L; Song Y
Chem Biol Interact; 2014 Feb; 209():56-67. PubMed ID: 24361488
[TBL] [Abstract][Full Text] [Related]
8. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
9. Capsaicin induces heme oxygenase-1 expression in HepG2 cells via activation of PI3K-Nrf2 signaling: NAD(P)H:quinone oxidoreductase as a potential target.
Joung EJ; Li MH; Lee HG; Somparn N; Jung YS; Na HK; Kim SH; Cha YN; Surh YJ
Antioxid Redox Signal; 2007 Dec; 9(12):2087-98. PubMed ID: 17979524
[TBL] [Abstract][Full Text] [Related]
10. Polydatin attenuates reactive oxygen species-induced airway remodeling by promoting Nrf2-mediated antioxidant signaling in asthma mouse model.
Zeng H; Wang Y; Gu Y; Wang J; Zhang H; Gao H; Jin Q; Zhao L
Life Sci; 2019 Feb; 218():25-30. PubMed ID: 30092299
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II induces oxidative stress and upregulates neuroprotective signaling from the NRF2 and KLF9 pathway in dopaminergic cells.
Parga JA; Rodriguez-Perez AI; Garcia-Garrote M; Rodriguez-Pallares J; Labandeira-Garcia JL
Free Radic Biol Med; 2018 Dec; 129():394-406. PubMed ID: 30315936
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin induces heme oxygenase-1 via NF-E2-related factor 2 (Nrf2) activation through ERK and PI3K/Akt pathway in colon cancer.
Jang HJ; Hong EM; Kim M; Kim JH; Jang J; Park SW; Byun HW; Koh DH; Choi MH; Kae SH; Lee J
Oncotarget; 2016 Jul; 7(29):46219-46229. PubMed ID: 27323826
[TBL] [Abstract][Full Text] [Related]
13. Polydatin attenuates spinal cord injury in rats by inhibiting oxidative stress and microglia apoptosis via Nrf2/HO-1 pathway.
Lv R; Du L; Zhang L; Zhang Z
Life Sci; 2019 Jan; 217():119-127. PubMed ID: 30481506
[TBL] [Abstract][Full Text] [Related]
14. NAD(P)H:quinone oxidoreductase 1 determines radiosensitivity of triple negative breast cancer cells and is controlled by long non-coding RNA NEAT1.
Lin LC; Lee HT; Chien PJ; Huang YH; Chang MY; Lee YC; Chang WW
Int J Med Sci; 2020; 17(14):2214-2224. PubMed ID: 32922184
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of pterostilbene against oxidative stress injury: Involvement of nuclear factor erythroid 2-related factor 2 pathway.
Wang B; Liu H; Yue L; Li X; Zhao L; Yang X; Wang X; Yang Y; Qu Y
Brain Res; 2016 Jul; 1643():70-9. PubMed ID: 27107941
[TBL] [Abstract][Full Text] [Related]
16. Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway.
Xiang Y; Ye W; Huang C; Yu D; Chen H; Deng T; Zhang F; Lou B; Zhang J; Shi K; Chen B; Zhou M
Oxid Med Cell Longev; 2018; 2018():2360427. PubMed ID: 29849873
[TBL] [Abstract][Full Text] [Related]
17. Activation of Nrf2/HO-1 signaling: An important molecular mechanism of herbal medicine in the treatment of atherosclerosis
Zhang Q; Liu J; Duan H; Li R; Peng W; Wu C
J Adv Res; 2021 Dec; 34():43-63. PubMed ID: 35024180
[TBL] [Abstract][Full Text] [Related]
18. Polydatin attenuates orbital oxidative stress in Graves' orbitopathy through the NRF2 pathway.
Li H; Min J; Chen Y; Li H; Zhang Y
Chem Biol Interact; 2020 Jan; 315():108894. PubMed ID: 31705858
[TBL] [Abstract][Full Text] [Related]
19. Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth.
Woodcock CC; Huang Y; Woodcock SR; Salvatore SR; Singh B; Golin-Bisello F; Davidson NE; Neumann CA; Freeman BA; Wendell SG
J Biol Chem; 2018 Jan; 293(4):1120-1137. PubMed ID: 29158255
[TBL] [Abstract][Full Text] [Related]
20. Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNBC) progression and M2 macrophage functions under the oncogenic stress.
Al Haq AT; Tseng HY; Chen LM; Wang CC; Hsu HL
Cell Death Dis; 2022 Jan; 13(1):49. PubMed ID: 35017469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
